AI in Diagnostics is mainly focusing on solving patient safety issues caused by known problems with diagnostic testing. Many diagnostic issues are data-driven and resolving them requires new data-science based approaches. AI in Diagnostics is focusing on using innovative AI and machine-learning to improve diagnostic accuracy and cut costs – improving patient safety worldwide.

Market Analysis and Insights: Global Artificial Intelligence Diagnostics Market
The global Artificial Intelligence Diagnostics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Artificial Intelligence Diagnostics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Artificial Intelligence Diagnostics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Artificial Intelligence Diagnostics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Artificial Intelligence Diagnostics market.

Global Artificial Intelligence Diagnostics Scope and Market Size
Artificial Intelligence Diagnostics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Artificial Intelligence Diagnostics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Radiology
Oncology
Neurology
Cardiology
Chest & Lungs
Other Diagnosis Types

Segment by Application
Services
Software
Hardware

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
General Electric (GE) Co. (GE Healthcare)
Siemens AG (Siemens Healthineers)
Aidoc Medical Ltd.
AliveCor, Inc.
Imagen Technologies, Inc.
VUNO, Inc.
IDx Technologies, Inc.
NovaSignal Corporation
Riverain Technologies, LLC
Zebra Medical Vision Ltd.
OSP Lab
Tessella
Philips